News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
528,496 Results
Type
Article (31417)
Company Profile (127)
Press Release (496952)
Multimedia
Podcasts (37)
Webinars (9)
Section
Business (162261)
Career Advice (1878)
Deals (27859)
Drug Delivery (88)
Drug Development (56872)
Employer Resources (163)
FDA (12091)
Job Trends (11060)
News (264720)
Policy (24748)
Tag
Academia (2028)
Academic (2)
Accelerated approval (4)
Adcomms (26)
Allergies (65)
Alliances (38083)
ALS (66)
Alzheimer's disease (1077)
Antibody-drug conjugate (ADC) (105)
Approvals (12094)
Artificial intelligence (225)
Autoimmune disease (16)
Automation (12)
Bankruptcy (216)
Best Places to Work (8820)
BIOSECURE Act (12)
Biosimilars (77)
Biotechnology (85)
Bladder cancer (59)
Brain cancer (23)
Breast cancer (193)
Cancer (1685)
Cardiovascular disease (127)
Career advice (1570)
Career pathing (32)
CAR-T (114)
Cell therapy (332)
Cervical cancer (14)
Clinical research (46264)
Collaboration (677)
Compensation (417)
Complete response letters (28)
COVID-19 (1722)
CRISPR (35)
C-suite (221)
Cystic fibrosis (75)
Data (1699)
Decentralized trials (1)
Denatured (24)
Depression (32)
Diabetes (202)
Diagnostics (5144)
Digital health (12)
Diversity (7)
Diversity, equity & inclusion (42)
Drug discovery (89)
Drug pricing (59)
Drug shortages (8)
Duchenne muscular dystrophy (73)
Earnings (69261)
Editorial (18)
Employer branding (24)
Employer resources (141)
Events (80702)
Executive appointments (647)
FDA (13107)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (6)
Funding (613)
Gene editing (83)
Generative AI (21)
Gene therapy (213)
GLP-1 (509)
Government (2800)
Grass and pollen (2)
Guidances (62)
Healthcare (12985)
Huntington's disease (16)
IgA nephropathy (19)
Immunology and inflammation (67)
Indications (26)
Infectious disease (1829)
Inflammatory bowel disease (119)
Inflation Reduction Act (7)
Influenza (38)
Intellectual property (91)
Interviews (315)
IPO (13451)
IRA (20)
Job creations (2595)
Job search strategy (1322)
Kidney cancer (8)
Labor market (38)
Layoffs (329)
Leadership (19)
Legal (5005)
Liver cancer (58)
Lung cancer (256)
Lymphoma (125)
Machine learning (4)
Management (51)
Manufacturing (225)
MASH (46)
Medical device (9879)
Medtech (9883)
Mergers & acquisitions (14916)
Metabolic disorders (467)
Multiple sclerosis (64)
NASH (14)
Neurodegenerative disease (66)
Neuropsychiatric disorders (13)
Neuroscience (1495)
NextGen: Class of 2025 (4536)
Non-profit (2935)
Now hiring (38)
Obesity (237)
Opinion (165)
Ovarian cancer (54)
Pain (66)
Pancreatic cancer (52)
Parkinson's disease (119)
Partnered (21)
Patents (189)
Patient recruitment (77)
Peanut (39)
People (47817)
Pharmaceutical (34)
Pharmacy benefit managers (2)
Phase I (13669)
Phase II (19612)
Phase III (16892)
Pipeline (1029)
Policy (70)
Postmarket research (1691)
Preclinical (6193)
Press Release (71)
Prostate cancer (76)
Psychedelics (28)
Radiopharmaceuticals (197)
Rare diseases (286)
Real estate (4469)
Recruiting (64)
Regulatory (18585)
Reports (52)
Research institute (1832)
Resumes & cover letters (342)
Rett syndrome (4)
RNA editing (4)
RSV (32)
Schizophrenia (62)
Series A (109)
Series B (70)
Service/supplier (9)
Sickle cell disease (37)
Special edition (9)
Spinal muscular atrophy (114)
Sponsored (20)
Startups (2896)
State (2)
Stomach cancer (10)
Supply chain (48)
Tariffs (17)
The Weekly (13)
Vaccines (437)
Venture capitalists (35)
Weight loss (145)
Women's health (23)
Worklife (18)
Date
Today (116)
Last 7 days (719)
Last 30 days (2091)
Last 365 days (25535)
2025 (8442)
2024 (27887)
2023 (32184)
2022 (41742)
2021 (44523)
2020 (41863)
2019 (34944)
2018 (26249)
2017 (26192)
2016 (24618)
2015 (29359)
2014 (22393)
2013 (18556)
2012 (20168)
2011 (21069)
2010 (19894)
Location
Africa (624)
Alabama (47)
Alaska (5)
Arizona (142)
Arkansas (5)
Asia (31607)
Australia (5357)
California (4621)
Canada (1799)
China (432)
Colorado (207)
Connecticut (215)
Delaware (125)
Europe (71017)
Florida (704)
Georgia (155)
Hawaii (1)
Idaho (40)
Illinois (364)
India (23)
Indiana (254)
Iowa (8)
Japan (148)
Kansas (78)
Kentucky (18)
Louisiana (10)
Maine (54)
Maryland (616)
Massachusetts (3483)
Michigan (181)
Minnesota (266)
Mississippi (1)
Missouri (62)
Montana (27)
Nebraska (21)
Nevada (49)
New Hampshire (47)
New Jersey (1389)
New Mexico (27)
New York (1427)
North Carolina (785)
North Dakota (8)
Northern California (2064)
Ohio (152)
Oklahoma (8)
Oregon (17)
Pennsylvania (1009)
Puerto Rico (9)
Rhode Island (25)
South America (914)
South Carolina (15)
Southern California (1754)
Tennessee (82)
Texas (660)
United States (17615)
Utah (135)
Virginia (105)
Washington D.C. (43)
Washington State (408)
West Virginia (3)
Wisconsin (54)
528,496 Results for "science applications international corporation saic".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
SAIC Employees Embrace Generative AI with the Launch of Tenjin GPT
Science Applications International Corp. announced the launch of Tenjin GPT, a new internal, generative Artificial Intelligence resource available to employees that harnesses cutting-edge AI capabilities to automate and optimize business processes.
May 30, 2024
·
4 min read
Business
SAIC Schedules First Quarter Fiscal Year 2025 Earnings Conference Call for June 3 at 10 A.M. ET
Science Applications International Corp. is scheduled to issue its first quarter fiscal year 2025 results before market open on Monday, June 3, 2024.
May 22, 2024
·
3 min read
BioCapital
SAIC to Realign Organization to Optimize Strategic Pivots and Increase Organic Growth
Science Applications International Corporation, a premier Fortune 500® technology integrator driving our nation’s digital transformation across the defense, space, civilian and intelligence markets, announced it will reorganize its business, effective February 3, 2024.
December 11, 2023
·
5 min read
Press Releases
Lobe Sciences Provides Corporate Update
April 7, 2025
·
8 min read
BioCapital
U.S. Army Reserve Awards SAIC $156 Million Contract for IT Service Management
Science Applications International Corp. has been awarded a $156 million contract to provide system support to the U.S. Army Reserve Command through their United States Army Reserve Command Information Technology Support Services contract.
January 11, 2024
·
4 min read
Press Releases
International Stem Cell Corporation Announces 2024 Fourth Quarter and Year-End Results
April 1, 2025
·
6 min read
Press Releases
Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference
May 1, 2025
·
2 min read
Press Releases
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
March 4, 2025
·
4 min read
Business
SAIC Announces CEO Transition - May 18, 2023
Science Applications International Corp. announced the appointment of 35-year global technology veteran Toni Townes-Whitley as the company’s Chief Executive Officer, effective October 2, 2023.
May 18, 2023
·
6 min read
Press Releases
Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine
April 22, 2025
·
8 min read
1 of 52,850
Next
